Salt-Induced Cardiac Hypertrophy Is Independent of Blood Pressure and Endothelin in Obese, Heart Failure-Prone SHHF Rats

References

• Radin MJ, Holycross BJ, Hoepf T, McCune SA. Increased salt sensitivity secondary to leptin resistance in SHHF rats is mediated by endothelin. Mol Cell Biochem. 2003; 242: 57–63
   PubMed Web of Science ®Google Scholar
• Fujiwara K, Hayashi K, Matsuda H, Kubota E, Honda M, Ozawa Y, Saruta T. Altered pressure natriuresis in obese Zucker rats. Hypertension. 1999; 33: 1470–1475
   PubMed Web of Science ®Google Scholar
• Carlson SH, Shelton J, White CR, Wyss JM. Elevated sympathetic activity contributes to hypertension and salt sensitivity in diabetic obese Zucker rats. Hypertension. 2000; 35: 403–408
   PubMed Web of Science ®Google Scholar
• Suzuki H, Ikenaga H, Hayashida T, Otsuka K, Kanno Y, Ohno Y, Ikeda H, Saruta T. Sodium balance and hypertension in obese and fatty rats. Kidney Int. 1996; 49(Suppl. 55)S150–S153
   Google Scholar
• Hall JE. Pathophysiology of obesity hypertension. Curr Hypertens Rep. 2000; 2: 39–47
   PubMedGoogle Scholar
• Rothermund L, Luckert S, Kobmehl P, Paul M, Kreutz R. Renal endothelin ETA/ETB receptor imbalance differentiates salt-sensitive from salt-resistant spontaneous hypertension. Hypertension. 2001; 37: 275–280
   PubMed Web of Science ®Google Scholar
• Lariviere R, Day R, Schiffrin EL. Increased expression of endothelin-1 gene in blood vessels of deoxycorticosterone acetate-salt hypertensive rats. Hypertension. 1993; 21: 916–920
   PubMed Web of Science ®Google Scholar
• Barton M, Vos I, Shaw S, Boer P, D'Uscio LV, Grone HJ, Rabelink TJ, Lattmann T, Moreau P, Luscher TF. Dysfunctional renal nitric oxide synthase as a determinant of salt-sensitive hypertension: mechanisms of renal artery endothelial dysfunction and role of endothelin for vascular hypertrophy and glomerulosclerosis. J Am Soc Nephrol. 2000; 11: 835–845
   PubMed Web of Science ®Google Scholar
• Kassab S, Miller MT, Novak J, Reckelhoff J, Clower B, Granger JP. Endothelin-A receptor antagonism attenuates the hypertension and renal injury in Dahl salt-sensitive rats. Hypertension. 1998; 31: 397–402
   PubMed Web of Science ®Google Scholar
• Bihorac A, Tezcan H, Ozener C, Oktay A, Akoglu E. Association between salt sensitivity and target organ damage in essential hypertension. Am J Hypertens. 1996; 13: 864–872
   Google Scholar
• De la Sierra A, Lluch MM, Pare JC, Coca A, Aguilera MT, Azqueta M, Urbano-Marquez A. Increased left ventricular mass in salt-sensitive hypertensive patients. J Human Hypertension. 1996; 10: 795–799
   PubMed Web of Science ®Google Scholar
• Unger RH. Minireview. Weapons of lean body mass destruction: The role of ectopic lipids in the metabolic syndrome. Endocrinol. 2003; 144: 5159–5165
   PubMed Web of Science ®Google Scholar
• Thakur V, Richards R, Reisin E. Obesity, hypertension, and the heart. Am J Med Sci. 2001; 321: 242–248
   PubMed Web of Science ®Google Scholar
• Ito H, Hirata Y, Hiroe M, Tsujino M, Adachi S, Takamoto T, Nitta M, Taniguchi K, Marumo F. ET-1 induces hypertrophy with enhanced expression of muscle specific genes in cultured neonatal rat cardiomyocytes. Circ Res. 1991; 69: 209–215
   PubMed Web of Science ®Google Scholar
• Ito H, Hirata Y, Adachi S, Tanaka M, Tsujino M, Koike A, Nogami A, Murumo F, Hiroe M. Endothelin-1 is an autocrine/paracrine factor in the mechanism of angiotensin II-induced hypertrophy in cultured rat cardiomyocytes. J Clin Invest. 1993; 92: 398–403
   PubMed Web of Science ®Google Scholar
• Yamazaki T, Komuro I, Kudoh S, Zou Y, Shiojima I, Hiroi Y, Mizuno T, Maemura K, Kurihara H, Aikawa R, Takano H, Yazaki Y. Endothelin-1 is involved in mechanical stress-induced cardiomyocyte hypertrophy. J Biol Chem. 1996; 271: 3221–3228
   PubMed Web of Science ®Google Scholar
• Ritchie RH, Schiebinger RJ, LaPointe MC, Marsh JD. Angiotensin II-induced hypertrophy of adult rat cardiomyocytes is blocked by nitric oxide. Am J Physiol Heart Circ Physiol. 1998; 275: H1370–H1374
   Web of Science ®Google Scholar
• Rakhit RD, Edwards RJ, Mockridge JW, Baydoun AR, Wyatt AW, Mann GE, Marber MS. Nitric oxide-induced cardioprotection in cultured rat ventricular myocytes. Am J Physiol Heart Circ Physiol. 2000; 278: H1211–H1217
   PubMed Web of Science ®Google Scholar
• Ishizuka T, Ernsberger P, Liu S, Bedol D, Lehman TM, Koletsky RJ, Friedman JE. Phenotypic consequences of a nonsense mutation in the leptin receptor gene (fak) in obese spontaneously hypertensive Koletsky rats (SHROB). J Nutr. 1998; 128: 2299–2306
   PubMed Web of Science ®Google Scholar
• Park SC, Liu-Stratton Y, Medeiros LC, McCune SA, Radin MJ. Effect of male sex and obesity on platelet arachidonic acid in spontaneous hypertensive heart failure rats. Exp Biol Med. 2004; 229: 657–664
   Web of Science ®Google Scholar
• Clozel M, Breu V, Gray GA, Kalina B, Loffler BM, Burri K, Cassal JM, Hirth G, Muller M, Neidhart W. Pharmacological characterization of bosentan, a new potent orally active nonpeptide endothelin receptor antagonist. J Pharmacol Exp Therapeutics. 1994; 270: 228–235
   PubMed Web of Science ®Google Scholar
• Iwanaga Y, Kihara Y, Inagaki K, Onozawa Y, Yoneda T, Kataoka K, Sasayama S. Differential effects of angiotensin II versus endothelin-1 inhibitions in hypertrophic left ventricular myocardium during transition to heart failure. Circulation. 2001; 104: 606–612
   PubMed Web of Science ®Google Scholar
• Iwanaga Y, Kihara Y, Hasegawa K, Inagaki K, Yoneda T, Kaburagi S, Araki M, Sasayama S. Cardiac endothelin-1 plays a critical role in the functional deterioration of left ventricles during the transition from compensatory hypertrophy to congestive heart failure in salt-sensitive hypertensive rats. Circulation. 1998; 98: 2065–2073
   PubMed Web of Science ®Google Scholar
• Ziolo MT, Bers DM. The real estate of NOS signaling. Location, location, location. Circ Res. 2003; 92: 1279–1281
   PubMed Web of Science ®Google Scholar
• Barouch LA, Harrison RW+, Skaf MW, Rosas GO, Cappola TP, Kobeissi ZA, Hobai IA, Lemmon CA, Burnett AL, O'Rouke B, Rodriguez ER, Huang PL, Lima JA, Berkowitz DE, Hare JM. Nitric oxide regulates the heart by spatial confinement of nitric oxide synthase isoforms. Nature. 2002; 416: 337–339
   PubMed Web of Science ®Google Scholar
• Ni Z, Vaziri ND. Effect of salt loading on nitric oxide synthase expression in normotensive rats. Am J Hypertens. 2001; 14: 155–163
   PubMed Web of Science ®Google Scholar
• Ni Z, Oveisi F, Vaziri ND. Nitric oxide synthase isotype expression in salt-sensitive and salt-resistant Dahl rats. Hypertension. 1999; 34: 552–557
   PubMed Web of Science ®Google Scholar
• Ikeda Y, Saito K, Kim J-I, Yokoyama M. Nitric oxide synthase isoform activities in kidney of Dahl salt-sensitive rats. Hypertension. 1995; 26: 1030–1034
   PubMed Web of Science ®Google Scholar
• Wedgwood S, Black SM. Endothelin-1 decreases endothelial NOS expression and activity through ETA receptor-mediated generation of hydrogen peroxide. Am J Physiol Lung Cell Mol Physiol. 2005; 288: L480–L487
   PubMed Web of Science ®Google Scholar
• Ramzy D, Rao V, Tumiati LC, Xu N, Sheshgiri R, Miriuka S, Delgado DH, Ross HJ. Elevated endothelin-1 levels impair nitric oxide homeostasis through a PKC-dependent pathway. Circulation. 2006; 114: I-319–I-326
   Web of Science ®Google Scholar
• Gonon AT, Erbas D, Broijersen A, Valen G, Pernow J. Nitric oxide mediates protective effect of endothelin receptor antagonism during myocardial ischemia and reperfusion. Am J Physiol Heart Circ Physiol. 2004; 286: H1767–H1774
   PubMed Web of Science ®Google Scholar
• Jesmin S, Zaedi S, Shimojo N, Iemitsu M, Masuzawa K, Yamaguchi N, Mowa CN I, II, Maeda S, Hattori Y, Miyauchi T. Endothelin antagonism normalizes VEGF signaling and cardiac function in STZ-induced diabetic rat hearts. Am J Physiol Endocrinol Metab. 2007; 292: E1030–E1040
   PubMed Web of Science ®Google Scholar